Gerresheimer stock rises 3.76 percent as cash flow improves
Published on 09/28/2026 at 10:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer stock (ISIN DE000A0LD6E6) was trading at EUR 27.02 on Xetra on September 28, 2026, at 10:23 a.m. CEST, up 3.76 percent from the prior close of EUR 26.04. The move puts the medical packaging company at a market capitalization of EUR 933.3 million while investors assess a mixed Q1 2026 operating picture.
Revenue grows while EBITDA falls
Gerresheimer lists its Q1 2026 update on August 27, 2026. According to Boerse Express, revenue increased from EUR 519 million in the year-earlier quarter to EUR 524 million in Q1 2026, a gain of 0.96 percent.
The profit trend was less favorable. Adjusted EBITDA declined from EUR 81 million to EUR 66 million, a decrease of 18.52 percent, showing that the modest revenue increase has not yet translated into stronger operating profitability.
Cash flow provides a counterpoint
Free cash flow improved from negative EUR 142 million in Q1 2025 to negative EUR 32 million in Q1 2026, a EUR 110 million improvement, according to Boerse Express. The figure remains negative, but the year-over-year change gives the cash-generation target more weight than the revenue increase alone.
The same report links the first-quarter update with Gerresheimer's portfolio restructuring and debt-reduction plans. It also identifies Containment and Delivery Systems and Primary Injectable Solutions as growth areas, while Moulded Glass was weaker. These contrasting signals explain why the stock's daily gain sits alongside a wide valuation debate.
Stock remains below its yearly high
Gerresheimer traded between EUR 25.98 and EUR 27.02 during the September 28, 2026 session. Its 52-week range was EUR 14.83 to EUR 38.32, leaving the reference price materially below the yearly high even after the 3.76 percent intraday gain.
Trading volume stood at 13,219 shares at 10:23 a.m. CEST. For investors, the key evidence is the split between EUR 524 million of Q1 revenue and the 18.52 percent adjusted EBITDA decline, with the EUR 110 million cash-flow improvement offering a separate measure of progress.
Gerresheimer stock snapshot
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- Ticker: GXI
- Trading venue: Xetra
- Price (as of September 28, 2026, 10:23 a.m. CEST): EUR 27.02
- Market capitalization: EUR 933.3 million (as of September 28, 2026)
- 52-week range: EUR 14.83-38.32 (as of September 28, 2026)
- Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution
